Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

Namodenoson (CF102) demonstrated a favorable safety profile in patients with advanced pancreatic ductal adenocarcinoma (PDAC) in a phase 2a clinical study, meeting the trial’s primary end point and ...

Scientists engineered a stabilized, native-like E1E2 glycoprotein complex from hepatitis C virus and incorporated it into a ...

In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...

Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a leading cause of cirrhosis and liver cancer. While antiviral drugs ...

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...

Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or delivering the wrong diagnosis.

"My plan is to get as well as I possibly can over the summer so that I can tour with my new movie Ernie & Emma this fall." ...

Detectable serum HBV RNA in chronic hepatitis B patients with undetectable viral DNA was associated with a 3.2-fold higher ...

Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a ...

Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...